Levetiracetam's effect on blood in adults with epilepsy
Part of Blood & lymphatic, Brain & nervous system clinical trials.
This study looks at how levetiracetam (a seizure medicine) affects blood cell counts in adults with epilepsy. If you have been taking only levetiracetam for at least 6 months, the study will check your blood levels to see if there are any changes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been taking levetiracetam (Keppra) as your only seizure medicine for at least 6 months.
- You do not have any other medical condition that could affect your blood counts.
- You are not taking any other anti-seizure medications.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for adults with uncontrolled epilepsy who have been taking a high dose of Levetiracetam alone for at least a year. It tests whether taking Levetiracetam three times a day works better than the usual schedule.
This trial tests if levetiracetam, a seizure medication, can prevent seizures in adults with Down syndrome who also have Alzheimer's disease. It aims to help manage a common complication and improve quality of life.
This study measures how much epilepsy medicine (lamotrigine, levetiracetam, or oxcarbazepine) your body absorbs during pregnancy and breastfeeding. It may help doctors better understand dosing and safety during these times.
This trial uses detailed brain tests to better match people with epilepsy to the right treatment. It may help by using “precision medicine” methods to understand what in the brain is driving seizures.
This study looks back at children who had a prolonged seizure (status epilepticus) and needed a second medicine after the first one didn't work. Doctors want to see how well levetiracetam works compared to phenytoin, so they can choose better treatments for future children.
This trial studies how to give levetiracetam to newborn babies with seizures. It’s trying to find a safe dose and see if it can help control seizures in early life.
Hear when a new Neutropenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.